Muller & Phipps (India) is engaged in marketing of over the counter medical preparation and home care products.Product Profile: a) Cavisan - Medicated Dental Cream b) Cavifast - Medicated Dental Cream c) Cavisan - Gum Astringent d) Nixoderm
MULLER AND PHIPPS INDIA LIMITED. C-204,2N? FLOOR, MADHAVA, BANDRA KURLA COMPLEX, MUMBAI-400 052. CIN: L63090MH1917PLC007897 September 07, 2026 The Secretary, Bombay Stock Exchange Limited, 1st Floor, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai —400001 Scrip Code: 501477 Dear Sir, Sub: Compliance under Regulation 47 of the SEBI (Listing Obligations & Disclosure...
Muller and Phipps India Limited has announced the publication of its unaudited financial results for the quarter ended June 30, 2026. The company reported a total income of 203.33, alongside a net loss of 10.02 for the quarter. This translates to diluted earnings per share of 0.00. These financial figures...
Muller and Phipps India Limited has announced its 109th Annual General Meeting (AGM) will be held on September 28. For this meeting, a record date of September 18 has been set, meaning shareholders registered by then are eligible to participate. The company's Register of Members and Share Transfer Books will...
